Proxima's GliaSite Brain Tumor Radiation Therapy 510(k) Expected In 2000
This article was originally published in The Gray Sheet
Executive Summary
Proxima Therapeutics plans to file a 510(k) with clinical data for its GliaSite radiation therapy system (RTS) in early 2000 for treatment of brain cancer.